The bipolar maze: a roadmap through translational psychopathology
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
This exciting issue of Acta Psychiatrica Scandinavica focusses on bipolar disorder from different perspectives, including epidemiology on age at onset 1, 2 and comorbidity 3, biomarkers 4, clinical trial methodology 5, treatment 6, and medication adherence 7, thus covering some of the hottest topics in current clinical research on this condition. Indeed, bipolar disorder research has blossomed over the past two decades 8, 9, and bipolar disorder units and programs are more widespread than ever 10. This condition has been now unprecedentedly renamed as 'the heartland of Psychiatry' 11, 12. However, there is still a huge disparity between the burden of this particular disease and the (little) amount of funding devoted to research in this area of biomedical research 13. Hence, because of its psychopathologic complexity and limited investment, the translational road from bench to bed and vice versa can be defined as a maze. We are at the point of starting to work on a reasonable roadmap to walk it through. The first challenge in the maze is the phenotype. DSM-5 has upgraded bipolar disorders at the same level as psychotic disorders and depressive disorders, which may seem reasonable. However, the DSM system seems to lead nowhere over the foreseeing future. There may be small incremental improvements, such as the dimensional assessment of mixed states 14, 15, but the questionable validity of the DSM constructs, along with the limited improvement as regards to their reliability 16, suggests that a shift in paradigm is necessary. This fact prompted a debate in United States between the American Psychiatric Association and the National Institute of Mental Health (NIMH) on the validity of DSM-5 and what were the alternatives, and the NIMH announced their proposal to fund research based on research domains criteria (RDoC), rather than DSM-5. The RDoC initiative can be seen as an attempt to build a neuroscience-based classification of mental disorders 17. The positive side of this project is the will to anchor the new classification to well established circuits and biological mechanisms: the downside, the actual risk of ending nowhere, at least from the clinical use perspective. There is no question that some of the findings that RDoC-related research may bring up over the coming years will enrich our current knowledge on what we call 'bipolar disorder' and beyond. But it is hard to foresee an alternative to the traditional phenotype of manic-depressive illness that clinicians may be able to recognize and treat. It is much more likely, thus, that future translational research looking into concepts such as 'positive valence' or 'systems for social processes' may assist in better defining the bipolar phenotype allowing for a real 'personalized or stratified medicine' 18, rather than replacing it. The ROAMER project (Roadmap for Mental Health Research in Europe) may provide guidance on how to implement the foundation for an alternative to the US radical shift in mental health research priorities represented by RDoC, at the European level. The World Health Organization may want to learn from RDoC and ROAMER to make their own proposal of diagnostic research criteria (which should not necessarily be the same as those used for clinical practice) for the International Classification of Diseases, 11th edition. After decades of research on the heritability of bipolar illness, still the best proof of it are the epidemiological studies (twin, adoption, and population studies), but we certainly made some progress in molecular genetics. The second challenge of the bipolar maze is the genotype. To date, very little of the heritability of bipolar disorder is explained by common polymorphisms 19. Two genes appear to be the strongest candidates from genome-wide association studies, the ANK3, a gene involved in the function of voltage gated sodium channels), and the CACNA1C, a gene encoding a protein that is part of a voltage dependent calcium channel 20, 21. Many other candidate genes have been identified as correlates of certain traits and behaviors, such as impulsivity or suicidality 22, 23, giving further support to the need of a new nosological model based on translational or molecular psychopathology. Hopefully the next generation of genetic studies using whole exome or whole genome screening may shed more light into the genetics of the syndrome and particularly into the molecular genetics of its psychopathological components. The studies that have looked into the structural and functional neuroimaging of bipolar disorder have also increased our understanding of the condition. Again, it would be unfair to say that we have not made substantial progress in our understanding of the brain structures involved in the bipolar phenotype, but it is also true that we lack a compelling model connecting genes, cells, circuits, and structures. Indeed, the third challenge of the bipolar maze is the functional neuroanatomy of the bipolar brain.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cuthbert, B. N. (2014) · World Psychiatry · doi:10.1002/wps.20087 · Cited by 1,377 · cited 1×
“The RDoC initiative can be seen as an attempt to build a neuroscience-based classification of mental disorders (17).”
BackgroundWellcome Trust Case Control Consortium, Ferreira, M. A. R., O'Donovan, M. C., Meng, Y. A., Jones, I. R., Ruderfer, D. M., Jones, L., Fan, J., Kirov, G., Perlis, R. H., et al. (2008) · Nature Genetics · doi:10.1038/ng.209 · Cited by 1,237 · cited 1×
“Two genes appear to be the strongest candidates from genome-wide association studies, the ANK3, a gene involved in the function of voltage gated sodium channels), and the CACNA1C, a gene encoding a protein that is part of a voltage dependent calcium channel (20, 21).”
BackgroundPacchiarotti, I., Bond, D. J., Baldessarini, R. J., Nolen, W. A., Grunze, H., Licht, R. W., Post, R. M., Berk, M., Goodwin, G. M., Sachs, G. S., et al. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2013.13020185 · Cited by 770 · cited 1×
“of antidepressants in this condition (68).”
Self-citationEfficacy of Functional Remediation in Bipolar Disorder: A Multicenter Randomized Controlled Study
Torrent, C., Bonnin, C. D. M., Martínez-Arán, A., Valle, J., Amann, B. L., González-Pinto, A., Crespo, J. M., Ibáñez, Á., Garcia-Portilla, M. P., Tabarés-Seisdedos, R., et al. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.12070971 · Cited by 330 · cited 1×
“As cognition is a crucial mediator of functional outcome, cognitive remediation techniques, and particularly functional remediation, have been successfully applied to patients with bipolar disorder (53).”
BackgroundSelf-citationThe Initial Field Trials of DSM-5: New Blooms and Old Thorns
Freedman, R., Lewis, D. A., Michels, R., Pine, D. S., Schultz, S. K., Tamminga, C. A., Gabbard, G. O., Gau, S. S.-F., Javitt, D. C., Oquendo, M. A., et al. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.12091189 · Cited by 295
Self-citationSubthreshold symptoms in bipolar disorder: Impact on neurocognition, quality of life and disability
Bonnín, C. M., Sánchez-Moreno, J., Martínez-Arán, A., Solé, B., Reinares, M., Rosa, A. R., Goikolea, J. M., Benabarre, A., Ayuso-Mateos, J. L., Ferrer, M., et al. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.10.012 · Cited by 190
Self-citationStratified medicine for mental disorders
Schumann, G., Binder, E. B., Holte, A., de Kloet, E. R., Oedegaard, K. J., Robbins, T. W., Walker-Tilley, T. R., Bitter, I., Brown, V. J., Buitelaar, J., et al. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.09.010 · Cited by 186
Self-citationOne‐year psychosocial functioning in patients in the early vs. late stage of bipolar disorder
Rosa, A. R., González‐Ortega, I., González‐Pinto, A., Echeburúa, E., Comes, M., Martínez‐Àran, A., Ugarte, A., Fernández, M., & Vieta, E. (2012) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2011.01830.x · Cited by 166
Self-citationPapakostas, G. I. (2014) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.13r08710 · Cited by 153
Pharmacological approaches in bipolar disorders and the impact on cognition: a critical overview
Dias, V. V., Balanzá‐Martinez, V., Soeiro‐de‐Souza, M. G., Moreno, R. A., Figueira, M. L., Machado‐Vieira, R., & Vieta, E. (2012) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2012.01910.x · Cited by 146
Self-citation
Cited by
Grande, I., Berk, M., Birmaher, B., & Vieta, E. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00241-x · Cited by 1,710
Self-citationVieta, E., Berk, M., Schulze, T. G., Carvalho, A. F., Suppes, T., Calabrese, J. R., Gao, K., Miskowiak, K. W., & Grande, I. (2018) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2018.8 · Cited by 891
Self-citationEarly Intervention in Bipolar Disorder
Vieta, E., Salagre, E., Grande, I., Carvalho, A. F., Fernandes, B. S., Berk, M., Birmaher, B., Tohen, M., & Suppes, T. (2018) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2017.17090972 · Cited by 354
Self-citationCognitive dysfunction in bipolar disorder and schizophrenia: a systematic review of meta-analyses
Carvalho, A. F., Bortolato, B., Miskowiak, K., Vieta, E., & Köhler, C. (2015) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s76700 · Cited by 306
Self-citationCognition as a target in schizophrenia, bipolar disorder and depression
Martinez-Aran, A., & Vieta, E. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.01.007 · Cited by 101
Self-citation
Metadata
- Authors
- Vieta, E.
- Venue
- Acta Psychiatrica Scandinavica
- Publisher
- Wiley
- Published
- 2014-03-18
- Volume
- 129
- Issue
- 5
- Pages
- 323-327
- ISSN
- 0001-690X (ISSN-L)
- 1600-0447
- OpenAlex
- W2082023554
- Cited by
- 54
- References
- 11
- FWCI
- 9.66
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The bipolar maze: a roadmap through translational psychopathology. https://app.cochat.ai/papers/10.1111/acps.12270
- The paper
- Vieta, E. (2014). The bipolar maze: a roadmap through translational psychopathology. Acta Psychiatrica Scandinavica. https://doi.org/10.1111/acps.12270
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.